Recharacterization of RSL3 reveals that the selenoproteome is a druggable target in colorectal cancer
RSL3 的重新表征表明，硒蛋白质组是结直肠癌的一个可用药靶点
期刊:
影响因子:
doi:10.1101/2024.03.29.587381
Stephen L DeAngelo, Liang Zhao, Sofia Dziechciarz, Myungsun Shin, Sumeet Solanki, Andrii Balia, Marwa O El-Derany, Cristina Castillo, Yao Qin, Nupur K Das, Hannah Noelle Bell, Joao A Paulo, Yuezhong Zhang, Nicholas J Rossiter, Elizabeth C McCulla, Jianping He, Indrani Talukder, Billy Wai-Lung Ng, Za
